CGEN - Latest News
Compugen Ltd. (CGEN), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $269.5M. Trailing twelve-month P/E ratio is 7.60. Beta to the broader market is 2.80.
The article list below shows the most recent CGEN headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent CGEN Headlines
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
prnewswire.com - May 12, 2026
HOLON, Israel, May 12, 2026 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in
Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026
prnewswire.com - May 4, 2026
HOLON, Israel, May 4, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in
Compugen to Participate in 25th Annual Needham Virtual Healthcare Conference
prnewswire.com - Apr 9, 2026
HOLON, Israel, April 9, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in
Compugen Q4 Earnings Call Highlights
defenseworld.net - Mar 4, 2026
Compugen (NASDAQ: CGEN) executives used the company's fourth-quarter and full-year 2025 earnings call to highlight a strengthened balance sheet follow
Compugen: Non-Dilutive Funding For Rilvegostomig Obtained And GS-0321 Advancement
seekingalpha.com - Mar 2, 2026
Compugen remains a 'Buy,' supported by pipeline progress, major pharma partnerships, and a cash runway extended into 2029. Key catalysts include the
How News Affects CGEN Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CGEN's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked CGEN news questions
- What is the latest CGEN news headline?
- The most recent CGEN headline (May 12, 2026) is "Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the CGEN news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What CGEN news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual CGEN options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.